Retatrutide (also known as LY3437943) is a triple-receptor agonist targeting three hormones: GIP, GLP-1, and glucagon. It’s being studied for treatment of obesity, overweight, type 2 diabetes, and for metabolic health.

No. Retatrutide remains under FDA investigation and is not yet officially approved.
Rest assured, our product is professionally compounded by a licensed pharmacy that maintains high standards of safety, quality, and compliance, ensuring your well-being and trust in every treatment.

Frequency depends on your body’s needs and health goals. Many start with a series of weekly treatments and then move to monthly maintenance for long-term benefits. Your provider will create a personalized plan for you.

Retatrutide is administered once a week, ideally on the same day each week for consistency. It can be taken with or without food, at any time of the day—what matters most is maintaining a regular schedule. The medication is given as a subcutaneous injection (under the skin).

• Gastrointestinal issues are the most common: nausea, vomiting, diarrhea, constipation.
• These side effects tend to be higher with larger doses and usually diminish over time with continued use. 

It may be helpful for patients with obesity or overweight, especially those who also have type 2 diabetes or NAFLD. The improvements seen in weight loss, metabolic markers, and liver fat suggest it could be valuable for metabolic health.

EMRA KIT

• 1 vial Tirzepatide (15mg)
• 1 Bacteriostatic Water (3ml)
• 1 x 3 cc syringe
• 1 x 1 cc syringe (insulin)
• 6 alcohol pads

Additional:

📄 Digital Weight Loss Tracker

🎥 Step-by-step Video Tutorial for Injection

💬 Guaranteed Ongoing Support

Of course. After your order is confirmed, we’ll provide detailed, step-by-step instructions and visual materials to guide you through your first injection.

And if you ever need extra help, our team is always here to support you.

No. We don’t provide medical prescriptions, and it’s important to consult your doctor before starting Tirzepatide.